JP2023175708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023175708A5 JP2023175708A5 JP2023136194A JP2023136194A JP2023175708A5 JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5 JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5
- Authority
- JP
- Japan
- Prior art keywords
- autoantigen
- alpha
- synuclein
- kit according
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192794 | 2015-11-03 | ||
| EP15192794.4 | 2015-11-03 | ||
| JP2018541534A JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
| PCT/EP2016/076372 WO2017076873A1 (en) | 2015-11-03 | 2016-11-02 | Method for vaccination against a self-antigen in a human patient |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Division JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023175708A JP2023175708A (ja) | 2023-12-12 |
| JP2023175708A5 true JP2023175708A5 (cg-RX-API-DMAC7.html) | 2024-04-01 |
| JP7628333B2 JP7628333B2 (ja) | 2025-02-10 |
Family
ID=54396782
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Active JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
| JP2023136194A Active JP7628333B2 (ja) | 2015-11-03 | 2023-08-24 | ヒト患者における自己抗原に対するワクチン接種法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Active JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12290553B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3370761A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7378931B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102857456B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108472344A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016348610B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018008697A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3003943A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2734924C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017076873A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3003943A1 (en) * | 2015-11-03 | 2017-05-11 | Affiris Ag | Method for vaccination against a self-antigen in a human patient |
| AR111760A1 (es) * | 2017-05-19 | 2019-08-14 | Novartis Ag | Compuestos y composiciones para el tratamiento de tumores sólidos mediante administración intratumoral |
| JP2021525074A (ja) * | 2018-05-22 | 2021-09-24 | ザ・ガバナーズ・オブ・ザ・ユニバーシティー・オブ・アルバータ | 構造に基づくアミロイド疾患ワクチン及び抗原のための無害な構造化足場 |
| JP7898188B2 (ja) | 2020-08-04 | 2026-07-31 | エイシー イミューン ソシエテ アノニム | 免疫原性化合物 |
| KR102527616B1 (ko) | 2021-03-18 | 2023-05-02 | 정성욱 | 항체 관련 정보를 제공하는 방법 및 디바이스 |
| IL314865A (en) | 2022-02-09 | 2024-10-01 | Ac Immune Sa | Anti-alpha-synuclein therapeutic vaccines |
| WO2025172592A1 (en) | 2024-02-15 | 2025-08-21 | Ac Immune Sa | Alpha synuclein therapeutic vaccine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101077416A (zh) | 2002-10-23 | 2007-11-28 | 葛兰素史密丝克莱恩生物有限公司 | 抗疟疾的疫苗接种方法 |
| AT413945B (de) | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT506535B1 (de) | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| AT508569A1 (de) | 2009-07-23 | 2011-02-15 | Affiris Ag | Pharmaceutical compound |
| AT508638B1 (de) | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| KR101660578B1 (ko) | 2009-09-03 | 2016-09-27 | 화이자 백신스 엘엘씨 | Pcsk9 백신 |
| JP5814933B2 (ja) | 2009-12-15 | 2015-11-17 | ノバルティス アーゲー | 免疫増強化合物の均質な懸濁物およびその使用 |
| EP2659907A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| EP2666785A1 (en) | 2012-05-23 | 2013-11-27 | Affiris AG | Complement component C5a-based vaccine |
| EP2703483A1 (en) | 2012-08-29 | 2014-03-05 | Affiris AG | PCSK9 peptide vaccine |
| PL3110439T3 (pl) | 2014-02-28 | 2019-09-30 | Affiris Ag | Szczepionki PCSK9 |
| CA3003943A1 (en) * | 2015-11-03 | 2017-05-11 | Affiris Ag | Method for vaccination against a self-antigen in a human patient |
-
2016
- 2016-11-02 CA CA3003943A patent/CA3003943A1/en active Pending
- 2016-11-02 WO PCT/EP2016/076372 patent/WO2017076873A1/en not_active Ceased
- 2016-11-02 KR KR1020187015512A patent/KR102857456B1/ko active Active
- 2016-11-02 RU RU2018120009A patent/RU2734924C2/ru active
- 2016-11-02 JP JP2018541534A patent/JP7378931B2/ja active Active
- 2016-11-02 US US15/772,572 patent/US12290553B2/en active Active
- 2016-11-02 EP EP16793798.6A patent/EP3370761A1/en active Pending
- 2016-11-02 BR BR112018008697-5A patent/BR112018008697A2/en not_active Application Discontinuation
- 2016-11-02 AU AU2016348610A patent/AU2016348610B2/en active Active
- 2016-11-02 CN CN201680064233.5A patent/CN108472344A/zh active Pending
-
2023
- 2023-08-24 JP JP2023136194A patent/JP7628333B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI232753B (en) | Adjuvant compositions comprising QS-21,3D-MPL and CpG and vaccine compositions comprising the same | |
| ES2179105T5 (es) | Adyuvantes proteinicos. | |
| JP2018532782A5 (cg-RX-API-DMAC7.html) | ||
| Brennan et al. | Cowpea mosaic virus as a vaccine carrier of heterologous antigens | |
| ES2141750T5 (es) | Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno. | |
| CN102256620B (zh) | 用于治疗阿尔茨海默氏病的免疫治疗组合物 | |
| JP2009191078A5 (cg-RX-API-DMAC7.html) | ||
| De Haan et al. | Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| Levi et al. | Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes | |
| JP2011042693A5 (cg-RX-API-DMAC7.html) | ||
| WO2002024224A2 (en) | Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen | |
| Migliorini et al. | Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity | |
| RU2018120009A (ru) | Способ вакцинации против аутоантигена у пациента-человека | |
| WO2013164354A1 (en) | Composition | |
| JP2007513992A (ja) | 自己免疫疾患の治療用のil−12又はil−23を含むワクチン | |
| AU2016271857B2 (en) | IL-23-P19 vaccines | |
| RU2130778C1 (ru) | Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка, дифтерии и коклюша | |
| MXPA06009805A (es) | Peptidos de interleucina 1 beta y factor de necrosis tumoral alfa y metodo de tratamiento utilizando los mismos. | |
| US20080311152A1 (en) | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer | |
| US8575319B2 (en) | Cleavable vaccine compositions and uses thereof and methods of making and using the same | |
| JP4889175B2 (ja) | 感染性因子に対する免疫応答を刺激するための組成物および方法 | |
| WO1998046263A1 (en) | Saponin adjuvants in combination with dna vaccination | |
| Allison | Antigens and adjuvants for a new generation of vaccines | |
| RU2130779C1 (ru) | Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка и дифтерии |